Therapeutic strategies for congenital myasthenic syndromes

Publisher： John Wiley & Sons Inc

E-ISSN： 1749-6632|1412|1|129-136

ISSN： 0077-8923

Source： ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol.1412, Iss.1, 2018-01, pp. : 129-136

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical and research strategies for limb‐girdle congenital myasthenic syndromes

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1412, Iss. 1, 2018-01 ,pp. : 102-112

John Wiley & Sons Inc

Access to resources Recommend Favorite

The unfolding landscape of the congenital myasthenic syndromes

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 25-34

John Wiley & Sons Inc

Access to resources Recommend Favorite

Congenital myasthenic syndromes with acetylcholinesterase deficiency, the pathophysiological mechanisms

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 104-110

John Wiley & Sons Inc

Access to resources Recommend Favorite

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)

By Chen Qiushi   Müller Juliane S.   Pang Poh-Choo   Laval Steve H.   Haslam Stuart M.   Lochmüller Hanns   Dell Anne  

Biomolecules, Vol. 5, Iss. 4, 2015-10 ,pp. : 2758-2781

MDPI

Access to resources Recommend Favorite

A presynaptic congenital myasthenic syndrome attributed to a homozygous sequence variant in LAMA5

By  

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, Vol. 1413, Iss. 1, 2018-02 ,pp. : 119-125

John Wiley & Sons Inc

Access to resources Recommend Favorite